Innovent Biologics Unveils Promising Data on IBI3055 for Autoimmune Treatment at Summit 2026 Innovent Biologics presents preclinical results of IBI3055, a tri-specific T cell engager aimed at treating autoimmune diseases, at the Immune Resetting Summit 2026.

Innovent Biologics Unveils Promising Data on IBI3055 for Autoimmune Treatment at Summit 2026 #China #Suzhou #Innovent_Biologics #IBI3055 #T_Cell_Engager